What it takes to make cancer research more inclusive
Drug Discovery World
AUGUST 16, 2022
These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery. . Instead, molecular markers are more accurate indicators of the patient’s associated risks. .
130 
Let's personalize your content